184 related articles for article (PubMed ID: 30112721)
1. Evaluation of stent placement for vena cava syndrome: phase II trial and phase III randomized controlled trial.
Takeuchi Y; Arai Y; Sone M; Sugawara S; Aramaki T; Sato R; Kichikawa K; Tanaka T; Morishita H; Ito T; Yamakado K; Baba Y; Kobayashi T
Support Care Cancer; 2019 Mar; 27(3):1081-1088. PubMed ID: 30112721
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous transluminal stenting for superior vena cava syndrome caused by malignant tumors: a single-center retrospective study.
Liu H; Li Y; Wang Y; Yan L; Zhou P; Han X
J Cardiothorac Surg; 2021 Mar; 16(1):39. PubMed ID: 33743767
[TBL] [Abstract][Full Text] [Related]
3. Endovascular stenting in the management of malignant superior vena cava obstruction: comparing safety, effectiveness, and outcomes between primary stenting and salvage stenting.
Leung ST; Sung TH; Wan AY; Leung KW; Kan WK
Hong Kong Med J; 2015 Oct; 21(5):426-34. PubMed ID: 26139689
[TBL] [Abstract][Full Text] [Related]
4. Technical and Anatomic Factors Influencing the Success of Inferior Vena Caval Stent Placement for Malignant Obstruction.
Devcic Z; Techasith T; Banerjee A; Rosenberg JK; Sze DY
J Vasc Interv Radiol; 2016 Sep; 27(9):1350-1360.e1. PubMed ID: 27117949
[TBL] [Abstract][Full Text] [Related]
5. Bridging Stent Placement in Vena Cava Syndrome With Tumor Thrombotic Extension in the Right Atrium.
Zander T; Caro VD; Maynar M; Rabellino M
Vasc Endovascular Surg; 2021 Jan; 55(1):69-72. PubMed ID: 32862786
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of endovascular Z-configuration stenting for malignant versus nonmalignant caval obstruction.
Han TM; Bondarev S; Keller EJ; Vogelzang RL; Resnick SA
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):939-944. PubMed ID: 32414673
[TBL] [Abstract][Full Text] [Related]
7. Safety and Effectiveness of Abre Self-Expanding Venous Stent for Treatment of Superior Vena Cava Syndrome.
An TJ; McNamara SL; Ardestani A; Zurkiya O; Cahalane A; Stecker MS; Epelboym Y; Burch E; Desai K; Kalva SP
Vasc Endovascular Surg; 2024 Aug; 58(6):617-622. PubMed ID: 38670555
[TBL] [Abstract][Full Text] [Related]
8. A new nitinol stent for use in superior vena cava syndrome. Initial clinical experience.
Andersen PE; Midtgaard A; Brenøe AS; Elle B; Duvnjak S
J Cardiovasc Surg (Torino); 2015 Dec; 56(6):877-81. PubMed ID: 26212865
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of large-bore uncovered stents for treating malignant superior vena cava syndrome.
Lim Choi S; Il Gwon D; Ha Kim G; Won Kim S; Oh CH; Ko GY
Eur J Radiol; 2024 Jun; 175():111446. PubMed ID: 38581861
[TBL] [Abstract][Full Text] [Related]
10. Treatment of malignant superior vena cava obstruction: metal stents or radiation therapy.
Nicholson AA; Ettles DF; Arnold A; Greenstone M; Dyet JF
J Vasc Interv Radiol; 1997; 8(5):781-8. PubMed ID: 9314368
[TBL] [Abstract][Full Text] [Related]
11. Endovascular stent-based revascularization of malignant superior vena cava syndrome with concomitant implantation of a port device using a dual venous approach.
Anton S; Oechtering T; Stahlberg E; Jacob F; Kleemann M; Barkhausen J; Goltz JP
Support Care Cancer; 2018 Jun; 26(6):1881-1888. PubMed ID: 29274029
[TBL] [Abstract][Full Text] [Related]
12. Is Long-Term Anticoagulation Required after Stent Placement for Benign Superior Vena Cava Syndrome?
Haddad MM; Thompson SM; McPhail IR; Bendel EC; Kalra M; Stockland AH; Neidert NB; Andrews JC; Misra S; Bjarnason H; Neisen MJ
J Vasc Interv Radiol; 2018 Dec; 29(12):1741-1747. PubMed ID: 30396845
[TBL] [Abstract][Full Text] [Related]
13. Follow-up results of 71 patients undergoing metallic stent placement for the treatment of a malignant obstruction of the superior vena cava.
Nagata T; Makutani S; Uchida H; Kichikawa K; Maeda M; Yoshioka T; Anai H; Sakaguchi H; Yoshimura H
Cardiovasc Intervent Radiol; 2007; 30(5):959-67. PubMed ID: 17546400
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome after intrahepatic venous stent placement for malignant inferior vena cava syndrome.
Brountzos EN; Binkert CA; Panagiotou IE; Petersen BD; Timmermans H; Lakin PC
Cardiovasc Intervent Radiol; 2004; 27(2):129-36. PubMed ID: 15259806
[TBL] [Abstract][Full Text] [Related]
15. The role of self-expanding vascular stent in superior vena cava syndrome for advanced tumours.
Irace L; Martinelli O; Gattuso R; Mingoli A; Fiori E; Alunno A; Di Girolamo A; Crocetti D; Sapienza P
Ann R Coll Surg Engl; 2021 Apr; 103(4):296-301. PubMed ID: 33682470
[TBL] [Abstract][Full Text] [Related]
16. Endovascular treatment of malignant superior vena cava syndrome secondary to lung cancer.
Calsina Juscafresa L; Gil Bazo I; Grochowicz L; Páramo Alfaro M; López-Picazo González JM; Moreno Jiménez M; Bilbao Jaureguizar JI
Hosp Pract (1995); 2017 Aug; 45(3):70-75. PubMed ID: 28618844
[TBL] [Abstract][Full Text] [Related]
17. Endovascular Treatment of Malignant Superior Vena Cava Syndrome through Upper-Limb Access: A Comparison between Venous-Dedicated and Conventional Stents.
Matthaiou N; Galanakis N; Kehagias E; Kontopodis N; Charalambous S; Kholcheva N; Tsetis K; Mavroudis D; Tsetis D
J Vasc Interv Radiol; 2020 Dec; 31(12):2066-2072. PubMed ID: 33127247
[TBL] [Abstract][Full Text] [Related]
18. Large-bore nitinol stents for malignant superior vena cava syndrome: factors influencing outcome.
Maleux G; Gillardin P; Fieuws S; Heye S; Vaninbroukx J; Nackaerts K
AJR Am J Roentgenol; 2013 Sep; 201(3):667-74. PubMed ID: 23971462
[TBL] [Abstract][Full Text] [Related]
19. Stent placement in superior vena cava syndrome.
Courtheoux P; Alkofer B; Al Refaï M; Gervais R; Le Rochais JP; Icard P
Ann Thorac Surg; 2003 Jan; 75(1):158-61. PubMed ID: 12537210
[TBL] [Abstract][Full Text] [Related]
20. Stent Implantation for Superior Vena Cava Syndrome of Malignant Cause.
Büstgens FA; Loose R; Ficker JH; Wucherer M; Uder M; Adamus R
Rofo; 2017 May; 189(5):423-430. PubMed ID: 28152555
[No Abstract] [Full Text] [Related]
[Next] [New Search]
